Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
ESSA Pharma Inc. (EPIX) had Earnings per Share (EPS) (Basic) of $-0.14 for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-5.96M |
|
-- |
|
-- |
|
$7.59M |
|
$-7.59M |
|
$1.63M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-5.96M |
|
$-7.59M |
|
$-7.57M |
|
44.13M |
|
44.13M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.14 |
$-0.14 |
|
| Balance Sheet Financials | |
$143.87M |
|
-- |
|
$0.62M |
|
$144.49M |
|
$3.53M |
|
-- |
|
$0.28M |
|
$3.81M |
|
$140.68M |
|
$140.68M |
|
$140.68M |
|
44.16M |
|
| Cash Flow Statement Financials | |
$-6.79M |
|
$8.23M |
|
$0.20M |
|
$33.70M |
|
$35.34M |
|
$1.64M |
|
$0.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
40.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.24% |
|
-4.24% |
|
-4.13% |
|
-4.24% |
|
$3.19 |
|
$-0.15 |
|
$-0.15 |
|